Investor Presentaiton
Geography wise performance - UK Business
Company Presence
■ One of the top 5 Indian pharma companies in the UK.
■Relonchem and Bell have partnered with leading UK
retailers including Tesco, ASDA, Morrisons, Boots for a
strong distribution footprint.
☐
Bell has a strong OTC portfolio with 450+ OTC/SKU products
Relonchem's portfolio comprises 162 MA's.
Overview of the market
■ The UK pharmaceutical market is estimated to grow by a
CAGR of 3.6% to ~USD 34.0 billion by 2023, driven primarily
by a universal coverage, growing disease burden and ease of
healthcare access.”
*
United Kingdom
(9MFY22)
454.1
©2021 - Marksans Pharma Limited, All Rights Reserved.
2.6%
(Cr.)
Total Revenue
Y-o-Y Growth
42.3%
Contribution
to Total Revenues
*Source: Internal estimates
26View entire presentation